QTREX Quantum Ltd.
QTREX Quantum Ltd. is a U.S.-listed technology company that develops advanced additively manufactured electronics and specialized hardware for quantum computing infrastructure and other mission-critical applications. The company also maintains a medical technology portfolio that includes respiratory support and blood monitoring platforms.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaConnectivity and interface hardware for quantum computing systems and cryostats.
Custom electronic components produced using the AME platform for specialized applications.
Hardware and electronic components for defense, aerospace, missile, and space uses.
Respiratory support and blood monitoring products and related portfolio assets.
Asiakkaat
QTREX sells to customers that need highly customized electronics rather than standard off-the-shelf components. Its recent disclosures point to government-owned industrial customers, quantum hardware buyers, and technical partners evaluating application-specific designs for cryogenic and control systems. The medical portfolio serves healthcare-related end markets through respiratory support and blood monitoring platforms.
Buy custom connectivity and interface hardware for dilution refrigerators, quantum processors, and control systems.
Buy proprietary Shielded RF Monolithic components after testing and qualification.
Buy AME-based electronics for mission-critical environments that need specialized performance.
Buy respiratory support and blood monitoring platforms or related portfolio assets.
Evaluate chip carrier samples and processor-interface designs for future program adoption.
Strategia
QTREX is building a direct-to-customer model for proprietary, application-specific components rather than only selling platform technology. It is also using its manufacturing infrastructure to pursue quantum, defense, aerospace, and other high-specification electronics markets while selectively monetizing parts of its medical portfolio.
Direct customer orders validate the move from development to recurring commercial supply.
In-house production and multi-technology manufacturing are central to customization and margin potential.
These markets reward specialized engineering and can diversify demand beyond quantum computing.
Selective monetization can simplify the portfolio and free resources for higher-priority electronics programs.
Maantiede
QTREX is a U.S.-listed company with operating and development activity centered in Israel, while selling into international markets. Recent disclosures reference customers outside its home market, including a leading international government-owned company, and the company presents its quantum hardware to industry participants in Boston and other commercial forums.
Riskit
QTREX depends on winning customer qualification, converting samples into purchase orders, and sustaining technical performance in niche hardware markets. It also carries going-concern and financing risk, while its cross-border operations add execution, customer concentration, and regulatory complexity.
- Going-concern and financing needVaikutus: KriittinenTodennäköisyys: Korkea
The filed financial statements note substantial doubt about continuing as a going concern and the need to raise capital.
Kohdistuu: Acquired AME operations and broader company funding needs
- Customer concentration and program dependencyVaikutus: KorkeaTodennäköisyys: Korkea
Early commercialization relies on a small number of qualified customers and follow-on purchase orders.
Kohdistuu: Quantum and Shielded RF component orders
- Qualification and adoption riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
Custom electronics require extensive testing, approval, and repeatability before larger deployment.
Kohdistuu: Sample-to-order conversion
- Export control and defense regulatory riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Defense, aerospace, missile, and space applications may trigger licensing and compliance obligations.
Kohdistuu: International and mission-critical customers
- Medical asset monetization riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen
The company is actively working to monetize parts of the medical business, which may not occur as planned.
Kohdistuu: Respiratory support and blood monitoring portfolio
Kirjanpito
Harkinnanvaraiset erätThe acquired AME business is being measured using preliminary fair values that may change as valuation work is completed.
Vaikutus: Could alter goodwill, intangibles, and future amortization
Management and auditors note substantial doubt and a need for additional capital.
Vaikutus: Affects liquidity assumptions and disclosure risk
Orders for specialized components may be recognized at shipment, delivery, or acceptance depending on terms.
Vaikutus: Can shift reported revenue across quarters
Acquired technology, equipment, and liabilities require judgmental valuation inputs.
Vaikutus: May affect balance sheet carrying values and future expenses
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Quanterix Corp
QTRX · Laboratory Analytical Instruments
Quanterix Corp develops and commercializes ultra-sensitive life science instruments, assay kits, and related services used to measure proteins and biomarkers in biological samples.
Regenerex Pharma, Inc.
Pharmaceutical Preparations
Qorvo, Inc.
QRVO · Semiconductors & Related Devices
Quantum Corporation
QMCO · Computer Storage Devices
Quantum Corp is a U.S.-based storage technology company that designs, manufactures, and sells primary storage, secondary storage, and data management solutions.
Varex Imaging Corp
VREX · Electronic Components, NEC
Varex Imaging Corp designs and manufactures X-ray imaging components and related systems used inside medical, security, and industrial inspection equipment.
Quantum X Inc.
QUTX · Services-Business Services, NEC
Päivitetty: 28.9.2026